Grzegorz S Nowakowski, MD

  • 4290 Citations
  • 41 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2001 2019

  • 4290 Citations
  • 41 Scopus h-Index
  • 126 Article
  • 7 Review article
  • 3 Letter
  • 1 Comment/debate
Article
34 Citations (Scopus)
Germinal Center
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Lymphoma
Therapeutics
41 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Survival
Disease-Free Survival
4 Citations (Scopus)

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses

McCarter, S. J., Vijayvargiya, P., Sidana, S., Nault, A. M., Lane, C. E., Lehman, J., Wilson, J. W., Parikh, S. A., Nowakowski, G. S. & Al-Kali, A., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Aspergillosis
Abscess
Central Nervous System
Lung
PCI 32765
49 Citations (Scopus)

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma

Witzig, T. E., Nowakowski, G. S., Habermann, T. M., Goy, A., Hernandez-Ilizaliturri, F. J., Chiappella, A., Vitolo, U., Fowler, N. & Czuczman, M. S., 2015, In : Annals of Oncology. 26, 8, p. 1667-1677 11 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Mantle-Cell Lymphoma
Therapeutics
lenalidomide
33 Citations (Scopus)

Alternative splicing regulates activation-induced cytidine deaminase (AID): Implications for suppression of AID mutagenic activity in normal and malignant B cells

Wu, X., Darce, J. R., Chang, S. K., Nowakowski, G. S. & Jelinek, D. F., Dec 1 2008, In : Blood. 112, 12, p. 4675-4682 8 p.

Research output: Contribution to journalArticle

Alternative Splicing
B-Lymphocytes
Cells
Germinal Center
Genetic Recombination

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
17 Citations (Scopus)

Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages

Church, A. K., Vandermeid, K. R., Baig, N. A., Baran, A. M., Witzig, T. E., Nowakowski, G. S. & Zent, C. S., Jan 1 2016, In : Clinical and Experimental Immunology. 183, 1, p. 90-101 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Phagocytosis
Macrophages
Monoclonal Antibodies
Antibodies
5 Citations (Scopus)

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
Lymphoma
B-Cell Lymphoma
17 Citations (Scopus)

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma

Witzig, T. E., Wiseman, G. A., Maurer, M. J., Habermann, T. M., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Link, B. K., Zent, C. S., Johnston, P. B., Shanafelt, T. D., Allmer, C., Asmann, Y., Gupta, M., Ballas, Z. K., Smith, B. J. & Weiner, G. J., Jul 2013, In : American Journal of Hematology. 88, 7, p. 589-593 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Oligodeoxyribonucleotides
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
B-Lymphocytes
97 Citations (Scopus)

A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

Nowakowski, G. S., McCollum, A. K., Ames, M. M., Mandrekar, S. J., Reid, J. M., Adjei, A., Toft, D. O., Safgren, S. L. & Erlichman, C., Oct 15 2006, In : Clinical Cancer Research. 12, 20 PART 1, p. 6087-6093 7 p.

Research output: Contribution to journalArticle

tanespimycin
Maximum Tolerated Dose
Neoplasms
Pharmacokinetics
Proteins
15 Citations (Scopus)

A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG)

Sammassimo, S., Pruneri, G., Andreola, G., Montoro, J., Steffanoni, S., Nowakowski, G. S., Gandini, S., Negri, M., Habermann, T. M., Raderer, M., Li, Z. M., Zinzani, P. L., Adam, P., Zucca, E. & Martinelli, G., 2015, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

Lymphoma
Retrospective Studies
Lung
Therapeutics
Disease-Free Survival
13 Citations (Scopus)

A roadmap for discovery and translation in lymphoma

Weinstock, D. M., Dalla-Favera, R., Gascoyne, R. D., Leonard, J. P., Levy, R., Lossos, I. S., Melnick, A. M., Nowakowski, G. S., Press, O. W., Savage, K. J., Shipp, M. A. & Staudt, L. M., Mar 26 2015, In : Blood. 125, 13, p. 2175-2177 3 p.

Research output: Contribution to journalArticle

Molecular Targeted Therapy
Translational Medical Research
Genetic Association Studies
Cooperative Behavior
Biomedical Research
56 Citations (Scopus)

A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells

Nowakowski, G. S., Dooner, M. S., Valinski, H. M., Mihaliak, A. M., Quesenberry, P. J. & Becker, P. S., 2004, In : Stem Cells. 22, 6, p. 1030-1038 9 p.

Research output: Contribution to journalArticle

Peptide Library
Hematopoietic Stem Cells
Bone Marrow
Peptides
Stem Cells
20 Citations (Scopus)

AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., Pinto, A., Re, F., Fogliatto, L. M., Scheinberg, P., Flinn, I. W., Moreira, C., Cabeçadas, J., Liu, D., Kalambakas, S., Fustier, P. & 2 others, Wu, C. & Gribben, J. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1188-1199 12 p.

Research output: Contribution to journalArticle

Open Access
Lymphoma
Placebos
Neutropenia
Disease-Free Survival
lenalidomide
54 Citations (Scopus)

BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma

Correia, C., Schneider, P. A., Dai, H., Dogan, A., Maurer, M. J., Church, A. K., Novak, A. J., Feldman, A. L., Wu, X., Ding, H., Meng, X. W., Cerhan, J. R., Slager, S. L., Macon, W. R., Habermann, T. M., Karp, J. E., Gore, S. D., Kay, N. E., Jelinek, D. F., Witzig, T. E. & 2 others, Nowakowski, G. S. & Kaufmann, S. H., Jan 22 2015, In : Blood. 125, 4, p. 658-667 10 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Mutation
Lymphoma
Immunoglobulins
Hazards
52 Citations (Scopus)

Bi-directional activation between mesenchymal stem cells and CLL B-cells: Implication for CLL disease progression

Ding, W. D., Nowakowski, G. S., Knox, T. R., Boysen, J. C., Maas, M. L., Schwager, S. M., Wu, W., Wellik, L. E., Dietz, A. B., Ghosh, A. K., Secreto, C. R., Medina, K. L., Shanafelt, T. D., Zent, C. S., Call, T. G. & Kay, N. E., Nov 2009, In : British Journal of Haematology. 147, 4, p. 471-483 13 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Mesenchymal Stromal Cells
Disease Progression
Coculture Techniques
Up-Regulation

Biological evaluation of CpG stimulation of normal human B-cells: Implications for B-cell biology and cytogenetic analysis of CLL B-cells

Wu, X., Smoley, S. A., Peterson, M. A., Walters, D. K., Arendt, B. K., Nowakowski, G. S., Van Dyke, D. L., Kay, N. E. & Jelinek, D. F., May 2011, In : British Journal of Haematology. 153, 3, p. 402-405 4 p.

Research output: Contribution to journalArticle

Karyotyping
CpG Islands
Cytogenetic Analysis
B-Cell Chronic Lymphocytic Leukemia
Cytogenetics
67 Citations (Scopus)
Integrin alpha4beta1
B-Cell Lymphoma
Mesenchymal Stromal Cells
Integrins
Apoptosis
43 Citations (Scopus)

Bowel perforation in intestinal lymphoma: Incidence and clinical features

Vaidya, R., Habermann, T. M., Donohue, J. H., Ristow, K. M., Maurer, M. J., Macon, W. R., Colgan, J. P., Inwards, D. J., Ansell, S. M., Porrata, L. F., Micallef, I., Johnston, P. B., Markovic, S. N., Thompson, C. A., Nowakowski, G. S. & Witzig Dr., T. E., Sep 2013, In : Annals of Oncology. 24, 9, p. 2439-2443 5 p., mdt188.

Research output: Contribution to journalArticle

Intestinal Perforation
Lymphoma
Incidence
B-Cell Lymphoma
Drug Therapy
106 Citations (Scopus)

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: A prognostic parameter with therapeutic potential

Shanafelt, T. D., Geyer, S. M., Bone, N. D., Tschumper, R. C., Witzig, T. E., Nowakowski, G. S., Zent, C. S., Call, T. G., LaPlant, B., Dewald, G. W., Jelinek, D. F. & Kay, N. E., Mar 2008, In : British Journal of Haematology. 140, 5, p. 537-546 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Observational Studies
Therapeutics
Fluorescence In Situ Hybridization
20 Citations (Scopus)

Chronic lymphoproliferative disorder of natural killer cells: A distinct entity with subtypes correlating with normal natural killer cell subsets

Morice, W. G., Jevremovic, D., Olteanu, H., Roden, A., Nowakowski, G. S., Kroft, S., Hanson, C. A. & Kurtin, P. J., Apr 2010, In : Leukemia. 24, 4, p. 881-884 4 p.

Research output: Contribution to journalArticle

NK Cell Lectin-Like Receptor Subfamily B
CD56 Antigens
KIR Receptors
Immunophenotyping
Lymphoproliferative Disorders
141 Citations (Scopus)

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

Nowakowski, G. S., Witzig, T. E., Dingli, D. M., Tracz, M. J., Gertz, M., Lacy, M., Lust, J. A., Dispenzieri, A., Greipp, P. R., Kyle, R. A. & Rajkumar, S. V., Oct 2005, In : Blood. 106, 7, p. 2276-2279 4 p.

Research output: Contribution to journalArticle

Flow cytometry
Plasma Cells
Multiple Myeloma
Flow Cytometry
Plasmas
66 Citations (Scopus)

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies

Shanafelt, T. D., Lee, Y. K., Call, T. G., Nowakowski, G. S., Dingli, D. M., Zent, C. S. & Kay, N. E., Jun 2006, In : Leukemia Research. 30, 6, p. 707-712 6 p.

Research output: Contribution to journalArticle

Tea
B-Cell Chronic Lymphocytic Leukemia
Polyphenols
Appointments and Schedules
Anecdotes
12 Citations (Scopus)

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy

Farooq, U., Maurer, M. J., Thompson, C. A., Thanarajasingam, G., Inwards, D. J., Micallef, I., Macon, W., Syrbu, S., Lin, T., Lin, Y., Ansell, S. M., Nowakowski, G. S., Habermann, T. M., Cerhan, J. R. & Link, B. K., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Anthracyclines
Recurrence
Survival
Transplants
27 Citations (Scopus)

Clinical significance of monoclonal B cells in cerebrospinal fluid

Nowakowski, G. S., Call, T. G., Morice, W. G., Kurtin, P. J., Cook, R. J. & Zent, C. S., Jan 2005, In : Cytometry Part B - Clinical Cytometry. 63, 1, p. 23-27 5 p.

Research output: Contribution to journalArticle

Cerebrospinal Fluid
B-Lymphocytes
Mantle-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Population
42 Citations (Scopus)

Clonally related follicular lymphomas and langerhans cell neoplasms: Expanding the spectrum of transdifferentiation

West, D. S., Dogan, A., Quint, P. S., Tricker-Klar, M. L., Porcher, J. C., Ketterling, R. P., Law, M. E., McPhail, E., Viswanatha, D. S., Kurtin, P. J., Dao, L. N., Ritzer, R. D., Nowakowski, G. S. & Feldman, A. L., Jul 2013, In : American Journal of Surgical Pathology. 37, 7, p. 978-986 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Langerhans Cells
Neoplasms
Langerhans Cell Sarcoma
Lymph Nodes
4 Citations (Scopus)

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 63.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Central Nervous System
Recurrence
lenalidomide
16 Citations (Scopus)
cohort analysis
disease incidence
Molecular Epidemiology
epidemiology
research program
24 Citations (Scopus)
Thalidomide
Stem Cell Transplantation
Multiple Myeloma
Dexamethasone
Therapeutics
27 Citations (Scopus)

Complement dependent cytotoxicity in chronic lymphocytic leukemia: Ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement

Baig, N. A., Taylor, R. P., Lindorfer, M. A., Church, A. K., Laplant, B. R., Pavey, E. S., Nowakowski, G. S. & Zent, C. S., Nov 2012, In : Leukemia and Lymphoma. 53, 11, p. 2218-2227 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Complement Activation
Complement Membrane Attack Complex
ofatumumab
alemtuzumab
67 Citations (Scopus)
Stem Cell Transplantation
Multiple Myeloma
Cyclophosphamide
Intercellular Signaling Peptides and Proteins
Hematopoietic Stem Cell Mobilization
19 Citations (Scopus)

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia [9]

Shanafelt, T. D., Jelinek, D. F., Tschumper, R., Schwager, S., Nowakowski, G. S., DeWald, G. W. & Kay, N. E., Jul 1 2006, In : Journal of Clinical Oncology. 24, 19, p. 3218-3219 2 p.

Research output: Contribution to journalArticle

DNA Mutational Analysis
ZAP-70 Protein-Tyrosine Kinase
Immunoglobulin Heavy Chains
Chromosomal Instability
B-Cell Chronic Lymphocytic Leukemia
13 Citations (Scopus)

Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma

Ansell, S. M., Tang, H., Kurtin, P. J., Koenig, P. A., Nowakowski, G. S., Nikcevich, D. A., Nelson, G. D., Yang, Z., Grote, D. M., Ziesmer, S. C., Silberstein, P. T., Erlichman, C. & Witzig, T. E., May 2012, In : Leukemia. 26, 5, p. 1046-1052 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Follicular Lymphoma
T-Lymphocytes
Confidence Intervals
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival
104 Citations (Scopus)

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D. M., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M., 2010, In : Mayo Clinic Proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Guidelines
Therapeutics
Immunoglobulin M
Plasmapheresis
45 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
22 Citations (Scopus)

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias
77 Citations (Scopus)

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

Maurer, M. J., Bachy, E., Ghesquières, H., Ansell, S. M., Nowakowski, G. S., Thompson, C. A., Inwards, D. J., Allmer, C., Chassagne-Clément, C., Nicolas-Virelizier, E., Sebban, C., Lebras, L., Sarkozy, C., Macon, W. R., Feldman, A. L., Syrbu, S. I., Traverse-Glehan, A., Coiffier, B., Slager, S. L., Weiner, G. J. & 5 others, Witzig, T. E., Habermann, T. M., Salles, G., Cerhan, J. R. & Link, B. K., 2016, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Follicular Lymphoma
Confidence Intervals
Molecular Epidemiology
Mortality
Survival
26 Citations (Scopus)

Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma

Kelly, J. L., Drake, M. M., Fredericksen, Z. S., Asmann, Y., Liebow, M., Shanafelt, T. D., Feldman, A. L., Ansell, S. M., Macon, W. R., Herr, M. M., Wang, A. H., Nowakowski, G. S., Call, T. G., Habermann, T. M., Slager, S. L., Witzig, T. E. & Cerhan, J. R., Jul 2012, In : Cancer Causes and Control. 23, 7, p. 1017-1029 13 p.

Research output: Contribution to journalArticle

Solar System
Vitamin D
Non-Hodgkin's Lymphoma
Odds Ratio
Confidence Intervals
10 Citations (Scopus)

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Bennani, N., LaPlant, B. R., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Macon, W. R., Reeder, C. B., Mikhael, J. R., Northfelt, D. W., Ghobrial, I. M. & Witzig, T. E., May 1 2017, In : American Journal of Hematology. 92, 5, p. 448-453 6 p.

Research output: Contribution to journalArticle

Lymphoma
Therapeutics
Safety
Febrile Neutropenia
Everolimus
9 Citations (Scopus)

Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma

Witzig, T. E., Maurer, M. J., Habermann, T. M., Link, B. K., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Markovic, S. N., Johnston, P. B., Lin, Y., Thompson, C. A., Gupta, M., Katzmann, J. A. & Cerhan, J. R., Dec 1 2014, In : American Journal of Hematology. 89, 12, p. 1116-1120 5 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Light
Serum
51 Citations (Scopus)

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma

Maurer, M. J., Micallef, I., Cerhan, J. R., Katzmann, J. A., Link, B. K., Colgan, J. P., Habermann, T. M., Inwards, D. J., Markovic, S. N., Ansell, S. M., Porrata, L. F., Johnston, P. B., Nowakowski, G. S., Thompson, C. A., Gupta, M., Syrbu, S. I., Kurtin, P. J., Macon, W. R., Nikcevich, D. A. & Witzig, T. E., Apr 20 2011, In : Journal of Clinical Oncology. 29, 12, p. 1620-1626 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Light
Serum
Survival
81 Citations (Scopus)

Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment

Correia, C., Lee, S. H., Meng, X. W., Vincelette, N. D., Knorr, K. L. B., Ding, H., Nowakowski, G. S., Dai, H. & Kaufmann, S. H., Jul 1 2015, In : Biochimica et Biophysica Acta - Molecular Cell Research. 1853, 7, p. 1658-1671 14 p.

Research output: Contribution to journalArticle

Puma
Noxae
Apoptosis Regulatory Proteins
Follicular Lymphoma
Mitochondrial Membranes
6 Citations (Scopus)

Epilepsia partialis continua as an atypical presentation of cat scratch disease in a young adult

Nowakowski, G. S. & Katz, A., Dec 10 2002, In : Neurology. 59, 11, p. 1815-1816 2 p.

Research output: Contribution to journalArticle

Epilepsia Partialis Continua
Technetium Tc 99m Exametazime
Cat-Scratch Disease
X Ray Computed Tomography
Partial Epilepsy
3 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Lymphoma
Central Nervous System
Clinical Trials
25 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Safety
Disease-Free Survival
National Cancer Institute (U.S.)
Everolimus
3 Citations (Scopus)

Evolution: IMiDs to PPMs, revolution in DLBCL?

Nowakowski, G. S., Aug 6 2015, In : Blood. 126, 6, p. 698-700 3 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Blood
Cells
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
13 Citations (Scopus)

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

Bryce, A. H., Egan, J. B., Borad, M. J., Stewart, A. K., Nowakowski, G. S., Chanan Khan, A. A., Patnaik, M. M., Ansell, S. M., Banck, M. S., Robinson, S., Mansfield, A., Klee, E. W., Oliver, G. R., McCormick, J. B., Huneke, N. E., Tagtow, C. M., Jenkins, R. B., Rumilla, K. M., Kerr, S. E., Kocher, J-P. & 5 others, Beck, S. A., Fernandez-Zapico, M. E., Farrugia, G., Lazaridis, K. N. & Mc Williams, R. R., 2017, In : Oncotarget. 8, 16, p. 27145-27154 10 p.

Research output: Contribution to journalArticle

Genomics
Neoplasms
Precision Medicine
Standard of Care
Therapeutics
17 Citations (Scopus)

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the salivary glands: A multicenter, international experience of 248 patients (IELSG 41)

Jackson, A. E., Mian, M., Kalpadakis, C., Pangalis, G. A., Stathis, A., Porro, E., Conconi, A., Cortelazzo, S., Gaidano, G., Guillermo, A. L., Johnson, P. W., Martelli, M., Martinelli, G., Thieblemont, C., McPhail, E., Copie-Bergman, C., Pileri, S. A., Jack, A., Campo, E., Mazzucchelli, L. & 5 others, Ristow, K., Habermann, T. M., Cavalli, F., Nowakowski, G. S. & Zucca, E., Aug 12 2015, In : Oncologist. 20, 10, p. 1149-1153 5 p.

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
Salivary Glands
Therapeutics
Natural History
Multicenter Studies